Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
God I hope so
So do you know what came out of the meeting this week?
Oh yea, what ever came out of it?
Haha :)
20 MDA is over the 200 and the overall perfect 20/50/200 is setting up. Could be a winner or it could drop back down. Wish me luck, I have 19,000 shares of it :)
$IBIO lets see what happens now at this attempt to break .46
http://stockcharts.com/h-sc/ui?s=IBIO&p=D&b=5&g=0&id=p11632813173
That's what I'm banking on!
Homeboys, check out NCTY. I've held this bugger for quite awhile but I think its finally go time. Their huge game FireFall is finally being released at the end of this month.
Care to join BSB on this adventure?
So are you saying insurance won't come to fruition?
MELA Sciences Begins Insurance Reimbursement Process With Application for New CPT Code for the MelaFind System
IRVINGTON, N.Y., July 10, 2014 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (MELA), announced today that it has taken the first step in the process of seeking insurance reimbursement for its Multi-Spectral Digital Skin Lesion Analysis (MSDSLA) procedure that is performed by dermatologists utilizing the MelaFind(R) system as an aid in the detection of melanoma. The company has submitted an application for a Current Procedural Terminology (CPT(R)) code, which is necessary for Medicare Part B reimbursement by the Centers for Medicare and Medicaid Services (CMS). MSDSLA could be eligible for payment under Part B as early as January 1, 2016. The company will also commence efforts to obtain reimbursement from private insurance companies as the CMS review process proceeds
I hope they have news or a plan to support the new split price or we are f'ed!
Another brick in the wall of glory
It was just a letter that he sends out to people on a distribution list, very similar to what was on FB (unless this was also posted on FB).
PM or send me your email address and I'll fwd it over if you like!
Got Mail from Bob?
.026!
Maybe I'll go pay them a visit!
MMRF : New FB Post
New FB Post :
G'day USA ...
MMR Celebrates 4th of July 2014 in Australia
with US Ambassador John Berry
While in the U.S. Patent Ruling Could Substantially Narrow Defendants Prior Art References
MyMedicalRecords (MMR) is pleased with last Friday’s Court ruling. The ruling by the Court which was issued without prejudice to MMR's filing it again, states that “[t]he assertion of 27 prior-art references against claim 8 of the '466 patent is likely cumulative, duplicative, and excessive.” Furthermore the Court indicated that it expects defendants to “substantially” reduce the number of references voluntarily. Because the order is without prejudice MMR can raise the issue again after Markman unless the matter is resolved in meetings with defendants sooner which appears to be what the Court is suggesting. In other words, MMR can raise the issue again if need be.
This is an excellent outcome for now and it tees up the issue to be resolved shortly after receiving the Court’s claim construction opinion and that MMR can and is expected to raise the issue again if necessary.
MMR believes that the most relevant portion of the ruling is in the following language taken from the ruling exactly as it appears:
“The assertion of 27 prior-art references against claim 8 of the ’466 Patent is likely cumulative, duplicative, and excessive. But the Court is confident that the parties will be able to work together in good faith to substantially narrow the number of asserted claims and prior-art references after their respective positions have been informed by the Court’s claim-construction order.” (emphasis is from the Order)
In summary the Court order, basically tells the parties to cut down the issues, including prior art references, after issuance of the Courts’ Markman or claims construction ruling. If defendants don't do it at that time the Court basically invited MMR to bring the motion again.
In short it would appear that prior art references will be limited after Markman unless defendants do it voluntarily in a meet and confer process with MMR.
New FB Post :
G'day USA ...
MMR Celebrates 4th of July 2014 in Australia
with US Ambassador John Berry
While in the U.S. Patent Ruling Could Substantially Narrow Defendants Prior Art References
MyMedicalRecords (MMR) is pleased with last Friday’s Court ruling. The ruling by the Court which was issued without prejudice to MMR's filing it again, states that “[t]he assertion of 27 prior-art references against claim 8 of the '466 patent is likely cumulative, duplicative, and excessive.” Furthermore the Court indicated that it expects defendants to “substantially” reduce the number of references voluntarily. Because the order is without prejudice MMR can raise the issue again after Markman unless the matter is resolved in meetings with defendants sooner which appears to be what the Court is suggesting. In other words, MMR can raise the issue again if need be.
This is an excellent outcome for now and it tees up the issue to be resolved shortly after receiving the Court’s claim construction opinion and that MMR can and is expected to raise the issue again if necessary.
MMR believes that the most relevant portion of the ruling is in the following language taken from the ruling exactly as it appears:
“The assertion of 27 prior-art references against claim 8 of the ’466 Patent is likely cumulative, duplicative, and excessive. But the Court is confident that the parties will be able to work together in good faith to substantially narrow the number of asserted claims and prior-art references after their respective positions have been informed by the Court’s claim-construction order.” (emphasis is from the Order)
In summary the Court order, basically tells the parties to cut down the issues, including prior art references, after issuance of the Courts’ Markman or claims construction ruling. If defendants don't do it at that time the Court basically invited MMR to bring the motion again.
In short it would appear that prior art references will be limited after Markman unless defendants do it voluntarily in a meet and confer process with MMR.
LOL! I mean this is the Mountain HIGH Club for a reason!
Sorry! I thought you were just doing it to fill a spot while EZ was taking a break. If you want back on just let me know, no biggie whatsoever
Uncle EZ, did you get my email?
Edit : I took action on your PM
Obviously I'm outta the loop, what is this Zoo Pals nonsense you have made a sticky!?
I don't get it :(. Freight and logistics? Do tell :)
Global logix?
Hmm ive never been on that site before, do you use it?
Well they believe it....
MyMedicalRecords Signs Patent License Agreement With Salutopia http://t.co/3TvjFuzZCB
— Salutopia, Inc. (@salutopia) June 25, 2014
That last buy of 82800 was me, thanks for sharing!
I just bought 82k more
Great news I read this morning, but now we are in the red, what am I missing here.....
Volume precedes price, let's hope this is the last time we are at these levels
Thank you for the update!
Then who is buying those shares?
MMRF volume alert!
Hey you leave CO outta this
Giddy up
Let's get some!
$YGE
https://www.tradingview.com/v/qwLprJiy/
I'm in at 3.34, like the way this one is going, they are all over the World Cup and better numbers just came out
Check it out gang
Welcome new assistant mods, eZ and BJ!
Thanks guy :)
Hey EZ and gang, man I haven't been here for it seems weeks. Work has got busy and I can't easily get on here anymore, plus last week we went to Jamaica, ya mon!
As always I'm sitting here waiting to get rich.
Hope all of you have been doing well!
Yea I saw that, wtf was his problem?